Table 2.
Number of tolvaptan epissodes, days of tolvaptan treatment and duration of pNa maintenance for the ten monitored SCLC patients with confirmed SIADH
|
Case |
Number of tolvaptan episodes |
Days of tolvaptan treatment per episode |
Duration of pNa maintenance >125 mmol/l per episode [days] |
||||
|---|---|---|---|---|---|---|---|
| Median | Min | Max | Median | Min | Max | ||
| 1 |
8 |
4 |
1 |
6 |
6 |
4 |
49 |
| 2 |
3 |
3 |
1 |
3 |
11 |
4 |
199 |
| 3 |
5 |
7 |
5 |
102 |
14 |
3 |
45 |
| 4 |
1 |
4 |
4 |
4 |
614 |
614 |
614 |
| 5 |
1 |
4 |
4 |
4 |
301 |
301 |
301 |
| 6 |
6 |
2 |
2 |
6 |
25 |
12 |
177 |
| 7 |
2 |
5 |
3 |
7 |
22 |
10 |
34 |
| 8 |
15 |
4 |
1 |
18 |
11 |
2 |
29 |
| 9 |
3 |
3 |
2 |
4 |
16 |
8 |
24 |
| 10 |
3 |
2 |
2 |
2 |
19 |
5 |
22 |
| Total | 47 | 4 | 1 | 102 | 17,5 | 2 | 614 |